Effects of complete revascularization according to age in patients with ST-segment elevation myocardial infarction

Kevin R Bainey1, David A Wood2, Matthias Bossard3

  • 1Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, Alberta, Canada.

American Heart Journal
|October 23, 2023
PubMed

Insights

Complete revascularization in ST-segment elevation myocardial infarction (STEMI) benefits all patients, including older adults. This strategy reduces major cardiovascular events compared to treating only the culprit lesion, regardless of age.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Geriatric Cardiology

Background:

  • ST-segment elevation myocardial infarction (STEMI) management often involves percutaneous coronary intervention (PCI).
  • Complete revascularization reduces major cardiovascular events compared to culprit-lesion-only PCI in STEMI.
  • The impact of patient age on the benefits of complete revascularization remains unclear.

Purpose of the Study:

  • To investigate whether age influences the effectiveness of complete revascularization versus culprit-lesion-only PCI in STEMI patients.
  • To analyze treatment effects in patients aged ≥65 years compared to those <65 years.

Main Methods:

  • Subgroup analysis of the multinational randomized COMPLETE trial.
  • Comparison of complete revascularization versus culprit-lesion-only PCI.
  • Evaluation of two coprimary outcomes: cardiovascular death or new myocardial infarction, and cardiovascular death, new myocardial infarction, or ischemia-driven revascularization.
  • Stratification by age (≥65 years vs <65 years).

Main Results:

  • Older patients (≥65 years) had higher event rates for both coprimary outcomes.
  • Complete revascularization reduced the first coprimary outcome in both age groups (≥65 years: HR 0.77; <65 years: HR 0.72).
  • Complete revascularization significantly reduced the second coprimary outcome in both age groups (≥65 years: HR 0.56; <65 years: HR 0.48).
  • No significant interaction between age and treatment effect was observed for either outcome.

Conclusions:

  • Complete revascularization is beneficial for STEMI patients with multivessel coronary artery disease, irrespective of age.
  • The strategy of complete revascularization can be safely considered for older adults.
  • Age does not negate the benefits of complete revascularization in STEMI management.
Abstract

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.3K
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
30
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
9
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
9
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
12
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
11